KURA
Kura Oncology, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report0 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
+1.51%
vs ±10.2% implied · ×0.15
shaded = implied · ▲▼ = realized
Kura Oncology, Inc.
10.27
No thesis.
Fund move
Fund move
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | BlackRockBlackRockindex-like | $115.3M | 12.01% | +9.04% | |
| 2 | Suvretta Capital ManagementSuvretta | $94.1M | 9.80% | 0.00% | |
| 3 | BVFBVF | $92.7M | 9.66% | 0.00% | |
| 4 | State StreetState Streetindex-like | $58.5M | 6.09% | +18.11% | |
| 5 | Vanguard Capital ManagementVanguardindex-like | $43.0M | 4.48% | +3.45% | |
| 6 | Armistice CapitalArmistice Capital | $40.3M | 4.20% | −1.55% | |
| 7 | AQR Capital ManagementAQR | $34.3M | 3.57% | +47.18% | |
| 8 | Goldman Sachs GroupGoldman Sachs | $24.8M | 2.59% | +58.02% | |
| 9 | Geode Capital ManagementGeodeindex-like | $24.5M | 2.55% | +9.62% | |
| 10 | Alethea Capital ManagementAlethea | $23.8M | 2.48% | +41.75% | |
| 11 | Prosight ManagementProsight | $22.2M | 2.31% | −39.76% | |
| 12 | Deep Track CapitalDeep Track Capital | $21.7M | 2.26% | −25.15% | |
| 13 | Renaissance TechnologiesRenaissance Technologies | $18.3M | 1.90% | +5.13% | |
| 14 | Arrowstreet Capital, Limited PartnershipArrowstreet Capital, Limited Partnership | $15.5M | 1.61% | new | |
| 15 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $14.6M | 1.52% | +8.05% | |
| 16 | NAN Fung Trinity (hk)NAN Fung Trinity (hk) | $12.9M | 1.34% | +10.33% | |
| 17 | Qube Research & TechnologiesQube Research & Technologies | $12.8M | 1.34% | −28.52% | |
| 18 | Dimensional Fund AdvisorsDimensional | $12.8M | 1.34% | −18.01% | |
| 19 | Bank of AmericaBank of America | $12.7M | 1.33% | −5.63% | |
| 20 | Morgan StanleyMorgan Stanley | $12.7M | 1.33% | −0.32% | |
| 21 | Connor, Clark & Lunn Investment ManagementConnor, Clark & Lunn | $10.9M | 1.14% | +24.42% | |
| 22 | UBS GroupUBS | $10.6M | 1.10% | −7.27% | |
| 23 | Jacobs Levy Equity ManagementJacobs Levy Equity | $10.4M | 1.08% | +57.58% | |
| 24 | Northern TrustNorthern Trustindex-like | $9.1M | 0.95% | +9.90% | |
| 25 | Millennium ManagementMillennium | $7.8M | 0.81% | −54.55% |
220 managers report $959.6M of Kura Oncology on form 13F for the quarter ended Jun 30 '26. 27 of them hold 80% of it; BlackRock is largest at 12.01%.
Linked news
Expected move
Inputs8Q avg ±2.2%·×5.57·rich
straddle ±16.8%
spot 10.26exp Nov 20ATM strike 10ATM straddle 2.02IV 104%